Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001410578-22-003483
Filing Date
2022-11-17
Accepted
2022-11-17 17:30:09
Documents
76
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 6-K cvac-20220930x6k.htm   iXBRL 6-K 115484
2 EX-99.1 cvac-20220930xex99d1.htm   iXBRL EX-99.1 735275
3 EX-99.2 cvac-20220930xex99d2.htm EX-99.2 243772
4 EX-99.3 cvac-20220930xex99d3.htm EX-99.3 41677
5 GRAPHIC cvac-20220930xex99d1001.jpg GRAPHIC 9817
  Complete submission text file 0001410578-22-003483.txt   6049495

Data Files

Seq Description Document Type Size
6 EX-101.SCH cvac-20220930.xsd EX-101.SCH 95140
7 EX-101.CAL cvac-20220930_cal.xml EX-101.CAL 73814
8 EX-101.DEF cvac-20220930_def.xml EX-101.DEF 305819
9 EX-101.LAB cvac-20220930_lab.xml EX-101.LAB 645832
10 EX-101.PRE cvac-20220930_pre.xml EX-101.PRE 456300
70 EXTRACTED XBRL INSTANCE DOCUMENT cvac-20220930x6k_htm.xml XML 771758
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 221399728
SIC: 2834 Pharmaceutical Preparations